bioecon Member area
Technology · Biochemistry & industrial biotech / Enzymes & biocatalysis

Extensively hydrolyzed infant formulas

Multi-stage enzymatic cleavage of bovine whey and casein using food-grade endo- and exo-proteases combined with ultrafiltration (<3 kDa cut-off) to destroy milk allergen epitopes for hypoallergenic infant nutrition.

Food Processing & Nutrition Leisure, Welfare & Integration Maturity 9/9 Risk: medium Food ingredients Wellness & Preventive Bio-Living US · CN · EU verified 2026-11-15 · 1 Sources (1 independent)

1 · What it gives

Extensively hydrolyzed infant formulas represents an indispensable core capability in modern industrial biotechnology and green biocatalytic manufacturing, replacing energy-intensive chemical syntheses and toxic heavy-metal catalysts with highly selective enzymatic unit operations. By combining rational computational active-site redesign with laboratory directed evolution, biocatalysts are engineered to withstand non-physiological operating regimes, including non-aqueous solvent mixtures, high substrate concentrations, elevated temperatures up to 80°C, and extreme pH shifts. This paradigm shifts chemical production away from petrochemical reagents toward regenerative biological synthesis.

The technological platform integrates recombinant high-density microbial expression in Pichia pastoris or Bacillus, continuous cell disruption, covalent solid-phase immobilization onto macroporous polymer beads, and jacketed packed-bed flow reactor operations. State-of-the-art biotransformation systems achieve enantiomeric excess exceeding 99.5% with space-time yields surpassing 150 g/L/day. Manufacturing adheres to strict ISO 9001 and food/pharma cGMP standards, guaranteeing zero protein leaching into the product stream, enzyme carrier reusability over 500 operating cycles, and deterministic batch-to-batch reproducibility.

The key directions of this technology are:

  1. Computational Active-Site Engineering in Extensively hydrolyzed infant formulas: Utilizing structural bioinformatics, machine learning fitness landscapes, and Rosetta modeling to expand substrate scope and thermal stability.
  2. Advanced Solid-Phase Immobilization: Covalently anchoring biocatalysts onto epoxy-functionalized macroporous acrylic resins to maximize structural rigidity and prevent protein leaching.
  3. Multi-Enzyme Cascades & Cofactor Regeneration: Coupling auxiliary dehydrogenase loops to continuously regenerate expensive NAD(P)+ and ATP cofactors at catalytic turnover numbers exceeding 50,000.
  4. Process Analytical Technology (PAT) Flow Control: Deploying inline ATR-FTIR and Raman spectroscopy probes to continuously monitor substrate conversion and enzyme kinetics in continuous plug-flow reactors.

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Upstream Recombinant Host Cultivation         │
│  (Pichia pastoris / Bacillus fed-batch fermentation)   │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: High-Pressure Cell Lysis & Clarification      │
│  (800-1200 bar homogenization & depth microfiltration) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Covalent Carrier Immobilization               │
│  (Epoxy-functionalized resin coupling & crosslinking)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: Continuous Packed-Bed Biotransformation       │
│  (Jacketed plug-flow reactor under inline PAT control) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: Downstream Ultrafiltration & Crystallization  │
│  (10 kDa membrane catalyst retention & pure drying)    │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Recombinant Strain CultivationHigh-density aerobic fed-batch fermentation of microbial hosts expressing recombinant biocatalysts.In: Glucose carbon feedstock, mineral salts, trace vitamins.
Out: Dense cell biomass slurry with high intracellular/extracellular enzyme titer.
Cell Lysis & Enzyme HarvestingCell disruption via high-pressure homogenization followed by polymer flocculation and clarification.In: Concentrated cell slurry, lysis buffers, flocculating agents.
Out: Clarified enzyme lysate with enzyme recovery exceeding 85%.
Covalent Carrier ImmobilizationMultipoint covalent attachment onto macroporous amino/epoxy-polymethacrylate beads.In: Enzyme concentrate, functionalized polymer carrier, crosslinkers.
Out: Stable heterogeneous biocatalyst particles (protein loading 50-120 mg/g).
Continuous Flow BiotransformationStereoselective catalytic substrate conversion in jacketed packed-bed flow columns under closed control.In: Substrate solution, aqueous buffer, organic co-solvents, NAD(P)H.
Out: High-conversion product stream (>98% conversion, ee >99.5%).
Downstream Separation & PolishingCatalyst retention screening, 10 kDa ultrafiltration, anti-solvent crystallization, and vacuum drying.In: Crude reaction stream, anti-solvent, wash buffers.
Out: Compendial-grade finished biochemical / enzyme active (>99.0% purity).

Cross-cutting technologies of the sector:

  • High-Throughput Microfluidic Droplet Screening: Sorting directed evolution mutant libraries at rates exceeding 2,000 droplets per second in picoliter emulsions.
  • Inline Spectroscopic PAT Flow Cells: Multi-wavelength ATR-FTIR and Raman sensors providing automated feedback on reactant conversion and enantiomeric purity.

2 · What it replaces 6 · matched by industry

D1E2Microalgal omega-3 oils (DHA/EPA) instead of fish oil and krill oil
Replaces: Wild-capture fish oil and Antarctic krill oil for omega-3 (food, supplements, infant formula) and part of the aquafeed fish-oil fraction; …
FOOD
D2E–Enzymatic degumming (phospholipases) and enzymatic interesterification (immobilized lipases) of edible oils instead of acid–caustic chemical degumming and sodium-methoxide chemical interesterification
Replaces: Phosphoric/citric acid plus caustic soda degumming and neutralization (soapstock, wastewater, oil losses); chemical interesterification with …
FOOD
D3E–Enzymatic high-fructose syrup from starch instead of sucrose and acid hydrolysis
Replaces: Cane and beet sucrose in beverages and processed foods; acid hydrolysis of starch for glucose syrup
FOOD
D1E3Fermentation and plant-derived sweeteners instead of aspartame, saccharin and sucralose
Replaces: Artificial high-intensity sweeteners — aspartame (IARC 2B since 2023), saccharin, sucralose, acesulfame-K in beverages and dairy; part of …
FOOD
D1E–Baking enzymes (fungal amylase, maltogenic amylase, xylanase, glucose oxidase, lipase) plus ascorbic acid instead of potassium bromate and azodicarbonamide as flour treatment agents
Replaces: Potassium bromate (KBrO₃) and azodicarbonamide (ADA) used as oxidizing flour improvers/dough conditioners; part of chemical emulsifier use …
FOOD
D3E–Citric acid by Aspergillus niger fermentation instead of extraction from citrus fruit
Replaces: Citric acid extracted from lemons, limes and other citrus (calcium citrate route, Italy and California before 1930)
FOOD

3 · How to implement 5 steps

  1. 1
    Whey protein isolate reconstitution and thermal pre-treatmentprocessing
    Reconstituting 90% whey protein isolate (WPI) in demineralized water and pre-heating at 80°C to unfold globular beta-lactoglobulin conformations.
    Who can do this step matched automatically
    ✓ ISO 9001 industrial scale
    “Industrial supplier for Extensively hydrolyzed infant formulas”
  2. 2
    Multi-enzyme cascade hydrolysisprocessing
    Dosing optimized cocktails of food-grade endopeptidases (alcalase/trypsin) and exopeptidases (carboxypeptidase) in temperature-controlled bioreactors (50–55°C, pH 7.5–8.0).
    Who can do this step matched automatically
    ✓ ISO 9001 industrial scale
    “Industrial supplier for Extensively hydrolyzed infant formulas”
  3. 3
    Thermal enzyme inactivation and carbon debitteringprocessing
    Rapidly heating slurry to 90°C to permanently inactivate proteases, followed by specialized food-grade activated charcoal treatment to selectively adsorb bitter hydrophobic peptide terminals.
    Who can do this step matched automatically
    ✓ ISO 9001 industrial scale
    “Industrial supplier for Extensively hydrolyzed infant formulas”
  4. 4
    Precision 3 kDa ceramic ultrafiltrationprocessing
    Passing hydrolysate through 3,000 Dalton ceramic crossflow membrane cassettes to remove any residual intact protein chains or large allergenic peptides.
    Who can do this step matched automatically
    ✓ ISO 9001 industrial scale
    “Industrial supplier for Extensively hydrolyzed infant formulas”
  5. 5
    Multi-stage vacuum evaporation and spray dryingprocessing
    Concentrating sterile permeate to 50% solids under high vacuum and spray drying under cleanroom conditions, generating certified hypoallergenic peptide powder.
    Who can do this step matched automatically
    ✓ ISO 9001 industrial scale
    “Industrial supplier for Extensively hydrolyzed infant formulas”

4 · Who delivers

Matched suppliers (matched automatically)

CheckerspotUnited StatesProduceractive
Hetang Bioengineering (Wuxi) 禾糖生物ChinaProduceractive
ecovia bioUnited StatesResearch / RTOactive
Hofseth BiocareNorwayProduceractive
Perfect DayUnited StatesProduceractive
Quantec LtdNew ZealandProduceractive
Zero Cow FactoryIndiaProduceractive
Aspyre FoodsUnited StatesProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Novonesis (Novozymes)🇩🇰 DenmarkIndustrial Enzyme Platforms & Microbial SolutionsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Codexis🇺🇸 United StatesCodeEvolver Directed Evolution & API BiocatalystsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
BASF🇩🇪 GermanyIntegrated Chemical & Biocatalytic SynthesisStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Enzymaster🇨🇳 ChinaEngineered Biocatalysts & Chiral Fine ChemicalsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Lonza🇨🇭 SwitzerlandMicrobial CDMO & Custom Biocatalysis PlatformsStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale
Evonik Industries🇩🇪 GermanyFermentation Biosurfactants & Specialty IntermediatesStandardized cGMP / ISO 9001 biocatalytic validation and high-titer downstream isolation.Commercial Scale

5 · Rules & route to market

Route into Russia / EAEU: FOOD · Rospotrebnadzor / EAEU
declaration of conformity, or SGR within 30 calendar days for new/specialized ingredients (plus tests)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

DOE BETO and NSF synthetic biology grants, EPA TSCA and FDA GRAS regulatory frameworks#

  • DOE BETO & NSF Biomanufacturing Grants: Non-dilutive federal funding supporting high-performance enzyme platform scale-up for Extensively hydrolyzed infant formulas.
  • EPA TSCA Commercial Compliance: Regulatory submission of Microbial Commercial Activity Notices (MCANs) for novel genetically engineered production strains.
  • FDA GRAS & Food Contact Clearance: Pre-market safety affirmation for food-grade biocatalysts and Drug Master File (DMF) filings for pharmaceutical intermediates.

European Union

Circular Bio-based Europe JU (CBE JU), EFSA Regulation (EC) No 1332/2008, REACH authorization#

  • Circular Bio-based Europe Joint Undertaking: Strategic EU public-private partnerships financing fossil-decoupled biocatalytic manufacturing infrastructure.
  • EFSA Food Enzyme Scientific Dossiers: Rigorous genetic stability, allergenicity, and toxicological evaluations under Regulation (EC) No 1332/2008.
  • ECHA REACH Environmental Registration: Comprehensive ecotoxicity datasets and chemical safety reports demonstrating complete environmental biodegradability.

China

14th Five-Year Plan for the Bioeconomy, TIB CAS engineering hubs, national green manufacturing standards#

  • 14th Five-Year Bioeconomy Priority Program: National key R&D projects supporting biocatalysis and synthetic biology industrialization for 深度水解乳清与酪蛋白低敏婴儿配方奶基料.
  • TIB CAS & SIAT Industrial Platforms: World-class automated protein engineering foundries accelerating mutation library screening and bioprocess optimization.
  • NHC & SAMR Food Enzyme Standardization: Comprehensive compliance with national food safety standards (GB 1886.174) and environmental wastewater discharge limits.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. Engineered Biocatalytic Engine in Extensively hydrolyzed infant formulas:
    • Rational active-site remodeling via AlphaFold structure guidance and Rosetta molecular dynamics simulations.
    • Multi-gene directed evolution libraries screened in microfluidic double emulsions for enhanced thermotolerance up to 80°C.
  2. Heterogeneous Carrier & Reactor Chemistry:
    • Macroporous epoxy-activated acrylic beads providing high enzyme loading (50-120 mg/g) and zero leaching across 500 cycles.
    • Jacketed stainless-steel packed-bed columns operating under continuous plug-flow fluid dynamics with minimal pressure drops.
  3. Closed-Loop PAT & In-Situ Cofactor Recycling:
    • Coupled formate dehydrogenase enzymatic loops regenerating NADH cofactors at catalytic turnover numbers exceeding 50,000.
    • Real-time fiber-optic ATR-FTIR chemometric monitoring dynamically regulating substrate feed rates to prevent inhibition.

Sources 1 · 1 independent · 0 producer sites

Independent sources 1

  1. doi.org research checked 2026-11-15